Hemogenyx Pharmaceuticals (HEMO) News Today GBX 1.37 +0.05 (+3.79%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period May 25, 2024 | morningstar.comHemogenyx Pharmaceuticals PLC HEMOMay 20, 2024 | investing.comHemogenyx Pharmaceuticals PLC (HEMO)April 29, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023April 25, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Final ResultsApril 15, 2024 | msn.comSMALL CAP IDEA: Why investors should add Hemogenyx Pharmaceuticals to their watchlistMarch 30, 2024 | msn.comCompare with Oxurion NV (0G99)March 28, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Total Voting RightsMarch 13, 2024 | proactiveinvestors.comAlbo unveils ambitious $4 billion plan to overhaul remote housing in the Northern TerritoryMarch 12, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals discusses successful £3.5M capital raise as it advances HEMO-CAR-T programFebruary 29, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Placing to Raise US$4.2 millionFebruary 21, 2024 | lse.co.ukLondon pre-open: Stocks to nudge up; HSBC in focusFebruary 20, 2024 | finance.yahoo.comLung Cancer Research Foundation and American Lung Cancer Screening Initiative Join Forces for "Plus One" CampaignFebruary 20, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals achieves breakthrough with HEMO-CAR-T program, CBR platformFebruary 16, 2024 | lse.co.ukHemogenyx shares rise on potential for CBR to treat brain diseasesFebruary 16, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces CBR Brain DeliveryFebruary 14, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces CBR Intranasal DeliveryFebruary 9, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces FDA Consents to Phase I Trials of HEMO-CAR-TFebruary 2, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces the Approval and Issuance of U.S. Conditioning PatentJanuary 16, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Submission of Complete Response to Clinical HoldJanuary 8, 2024 | lse.co.ukHemogenyx Pharmaceuticals completes process qualification runNovember 28, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Placing to Raise £534,375November 27, 2023 | lse.co.ukHemogenyx shares up as says CBR platform a potential cancer treatmentNovember 27, 2023 | marketwatch.comHemoGenyx Says CBR Platform Could Potentially Be Used for Cancer TreatmentNovember 27, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces CBR Expanded to Treatment of CancerNovember 15, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Lentivirus Re-manufacturing CompletedSeptember 28, 2023 | lse.co.ukEARNINGS: Dar Global profit multiplies, Hemogenyx loss widensSeptember 18, 2023 | seekingalpha.comPrevail Partners to invest in Hemogenyx PharmaceuticalsSeptember 18, 2023 | marketwatch.comHemogenyx Stock Rises on Premium Share SubscriptionSeptember 14, 2023 | marketwatch.comHemogenyx Pharmaceuticals Says FDA Accepted Plans to Address Leukemia Treatment ConcernsSeptember 14, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC - Clinical Hold Lift Plan is accepted by FDASeptember 8, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces CBR Patent Application UpdateAugust 28, 2023 | finance.yahoo.comIs Hemogenyx Pharmaceuticals (LON:HEMO) In A Good Position To Deliver On Growth Plans?July 10, 2023 | lse.co.ukHemogenyx says Hemo-Car-T treatment placed on clinical hold by US FDAJuly 10, 2023 | marketwatch.comHemogenyx Pharmaceuticals Addresses FDA Concern on Leukemia Treatment; Shares RiseJuly 10, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Full FDA Review for HEMO-CAR-T INDJune 2, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Clinical Hold on IND for HEMO-CAR-TJune 2, 2023 | marketwatch.comHemogenyx Pharmaceuticals Shares Fall After FDA Puts Leukemia Treatment Application on HoldMay 9, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Submission of IND for HEMO-CAR-TMay 6, 2023 | bizjournals.comNew York Pharmaceuticals NewsApril 28, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Final Results for the Year Ended 31 December 2022April 28, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Equity Incentive Pool Increase and Option GrantMarch 23, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Analytical Release Tests CompletedMarch 20, 2023 | finance.yahoo.comWe're Not Very Worried About Hemogenyx Pharmaceuticals' (LON:HEMO) Cash Burn RateJanuary 26, 2023 | marketwatch.comHemogenyx Pharmaceuticals Shares Fall on Discounted Fund RaisingJanuary 26, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Placing to Raise £4,056,250January 25, 2023 | lse.co.ukHemogenyx Share News (HEMO)January 23, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T 3rd Process Qualification Run CompletedJanuary 9, 2023 | marketwatch.comHemoGenyx Shares Rise After Target Protein Discovery for Viral TreatmentJanuary 9, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Single CBR Can Treat Multiple VirusesJanuary 4, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Qualification Run Completed Get Hemogenyx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HEMO and its competitors with MarketBeat's FREE daily newsletter. Email Address This TSLA short trade is on a nine win hot streak (Ad)Most Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself. But I can promise that you’ll see all the details for yourself here. HEMO Media Mentions By Week HEMO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HEMO News Sentiment▼0.000.62▲Average Medical News Sentiment HEMO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HEMO Articles This Week▼00▲HEMO Articles Average Week Get Hemogenyx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HEMO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Poolbeg Pharma News Redx Pharma News e-therapeutics News Sareum News OptiBiotix Health News C4X Discovery News Arecor Therapeutics News Ondine Biomedical News BiVictriX Therapeutics News Synairgen News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:HEMO) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemogenyx Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemogenyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.